Aurinia Pharmaceuticals Inc. Files 8-K on Corporate Governance Changes
Ticker: AUPH · Form: 8-K · Filed: May 15, 2025 · CIK: 1600620
| Field | Detail |
|---|---|
| Company | Aurinia Pharmaceuticals Inc. (AUPH) |
| Form Type | 8-K |
| Filed Date | May 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, leadership-change, filing
Related Tickers: AUPH
TL;DR
Aurinia Pharma (AUPH) filed an 8-K detailing leadership changes and governance updates.
AI Summary
Aurinia Pharmaceuticals Inc. filed an 8-K on May 15, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. The filing also covers amendments to articles of incorporation or bylaws and changes in fiscal year, as well as the submission of matters to a vote of security holders.
Why It Matters
This filing provides updates on key leadership and governance changes within Aurinia Pharmaceuticals, which could impact the company's strategic direction and operational stability.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not indicate any immediate financial distress or significant negative events.
Key Players & Entities
- Aurinia Pharmaceuticals Inc. (company) — Registrant
- May 15, 2025 (date) — Date of Report
FAQ
What specific items are being reported in this 8-K filing by Aurinia Pharmaceuticals Inc.?
This 8-K filing reports on the departure of directors or certain officers, election of directors, appointment of certain officers, compensatory arrangements of certain officers, amendments to articles of incorporation or bylaws, change in fiscal year, and submission of matters to a vote of security holders.
What is the exact name of the registrant as specified in its charter?
The exact name of the registrant is Aurinia Pharmaceuticals Inc.
On what date was this 8-K report filed?
The report was filed on May 15, 2025.
What is the company's principal executive office address?
The company's principal executive office is located at #140, 14315 – 118 Avenue, Edmonton, Alberta T5L 4S6.
What is the IRS Employer Identification Number for Aurinia Pharmaceuticals Inc.?
The IRS Employer Identification Number for Aurinia Pharmaceuticals Inc. is 98-1231763.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 15, 2025 regarding Aurinia Pharmaceuticals Inc. (AUPH).